1-3 of 3
Jürgen Zimmermann
Close
Sort by
Journal Articles

Prognostication by miRNome-Profiling in Multiple Myeloma

Anja Seckinger, Tobias Meißner, Vladimir Benes, Sabine Schmidt, Jonathan Blake, Jürgen Zimmermann, Hartmut Goldschmidt, MD, Bernard Klein, Dirk Hose
Journal: Blood
Blood (2011) 118 (21): 1822.
https://doi.org/10.1182/blood.V118.21.1822.1822
Published: 2011
Journal Articles

Inhibition of HIF1A Signaling by a Novel Class of Sulfonanilides for Targeted Treatment of Multiple Myeloma.

Dirk Hose, Anja Seckinger, Hartmut Goldschmidt, Tobias Meiβner, Blanka Rebacz, Jerome Moreaux, Vladimir Benes, Kai Neben, Jens Hillengass, Uta Bertsch, Anna Jauch, Jean François Rossi, Thomas Möhler, Jürgen Zimmermann, Christof von Kalle, Joe Lewis, Bernard Klein, Christoph Schultes
Journal: Blood
Blood (2009) 114 (22): 2856.
https://doi.org/10.1182/blood.V114.22.2856.2856
Published: 2009
Journal Articles

Inhibition of Aurora-Kinases for Tailored Risk-Adapted Treatment of Multiple Myeloma

Dirk Hose, Thierry Rème, Tobias Meißner, Jérôme Moreaux, Anja Seckinger, Joe Lewis, Vladimir Benes, Axel Benner, Michael Hundemer, Thomas Hielscher, John D. Shaughnessy, Jr., PhD, Bart Barlogie, Kai Neben, Alwin Krämer, Jens Hillengass, Uta Bertsch, Anna Jauch, John De Vos, Jean François Rossi, Thomas Möhler, Jonathon Blake, Jürgen Zimmermann, Bernard Klein, Hartmut Goldschmidt
Journal: Blood
Blood (2008) 112 (11): 248.
https://doi.org/10.1182/blood.V112.11.248.248
Published: 2008